The Journal of Immunology, 1999, 163: 1636-1646.
Copyright © 1999 by The American Association of Immunologists
Chemokine Receptor Expression and Signaling in Macaque and Human Fetal Neurons and Astrocytes: Implications for the Neuropathogenesis of AIDS1
Robyn S. Klein2,*,
Kenneth C. Williams
,
Xavier Alvarez-Hernandez
,
Susan Westmoreland
,
Thomas Force
,
Andrew A. Lackner
and
Andrew D. Luster*
*
AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129;
New England Regional Primate Research Center, Harvard Medical School, Southboro, MA 01772; and
Cardiac Unit, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129
 |
Abstract
|
|---|
Chemokines are believed to play a role in the neuropathogenesis of
AIDS through their recruitment of neurotoxin-secreting, virally
infected leukocytes into the CNS. Levels of chemokines are elevated in
brains of patients and macaques with HIV/SIV-induced encephalitis. The
chemokine receptors CCR3, CCR5, and CXCR4 are found on subpopulations
of neurons in the cortex of human and macaque brain. We have developed
an in vitro system using both macaque and human fetal neurons and
astrocytes to further investigate the roles of these receptors in
neuronal response to inflammation. Here we report the presence of
functional HIV/SIV coreceptors CCR3, CCR5, and CXCR4 on fetal human and
macaque neurons and CCR5 and CXCR4 on astrocytes immediately ex vivo
and after several weeks in culture. Confocal imaging of immunostained
neurons demonstrated different patterns of distribution for these
receptors, which may have functional implications. Chemokine receptors
were shown to respond to their appropriate chemokine ligands with
increases in intracellular calcium that, in the case of neurons,
required predepolarization with KCl. These responses were blocked by
neutralizing chemokine receptor in mAbs. Pretreatment of neural cells
with pertussis toxin abolished responses to stromal-derived
factor-1
, macrophage inflammatory protein-1
, and RANTES,
indicating coupling of CCR5 and CXCR4 to a Gi
protein,
as in leukocytes. Cultured macaque neurons demonstrated calcium flux
response to treatment with recombinant SIVmac239 envelope protein,
suggesting a mechanism by which viral envelope could affect neuronal
function in SIV infection. The presence of functional chemokine
receptors on neurons and astrocytes suggests that chemokines could
serve to link inflammatory and neuronal
responses.
 |
Introduction
|
|---|
Human immunodeficiency virus type
1-associated
neurological disease is a devastating consequence of infection with
HIV-1 characterized by behavioral, motor, and memory disturbances
(1, 2). It has long been proposed that HIV-1-induced
neurologic disease is related to the production of toxins by virally
infected macrophages and possibly astrocytes, ultimately resulting in
neuronal dysfunction and/or loss (3, 4, 5, 6, 7). Several
neurotoxic factors have been proposed based on in vitro studies; these
include viral proteins, such as gp120 (8, 9) and tat
(10, 11), as well as a variety of immunologically active
molecules produced in response to infection (12, 13, 14),
including chemokines (15, 16, 17), whose effects on neuronal
function are unknown. Many of these factors can be produced by several
cell types within the CNS, including macrophages, lymphocytes, and
astrocytes (18, 19, 20, 21).
Although numerous complicated hypothesis have been proposed to explain
how the viral or cellular products of HIV-1-infected cells damage
neurons, the recent discovery that the chemokine receptors CXCR4, CCR3,
and CCR5, which act as coreceptors for HIV entry into lymphocytes and
macrophages (22, 23, 24), are also present on neurons suggests
new and simpler mechanisms. Chemokine receptors are members of the
seven-transmembrane-spanning G protein-coupled receptor superfamily and
thus are thought to exert their biological effects via multiple signal
transduction pathways (25). Most of the chemokine
receptors are expressed by several leukocyte cell types and have been
shown to be coupled to the pertussis toxin-sensitive
Gi
proteins (25). CCR3, CCR5, and
CXCR4 have been detected on subpopulations of large hippocampal and
neocortical pyramidal neurons and on glial cells in both normal and
encephalitic human and macaque brains (26, 27, 28, 29, 30, 31), and on
human fetal neurons in vitro (32, 33). CXCR4 and CCR5 mRNA
have also been detected in cultured rat glial and neuronal cells
(34, 35). Studies on cultured murine microglia and
astrocytes, rat hippocampal neurons, and neurons prepared from the
teratoma cell line, NT2, have demonstrated that CCR5 and CXCR4
chemokine ligands induce calcium transients and chemotaxis in these
cell types (36, 37, 38). It is not known whether HIV-1
chemokine coreceptors expressed on cultured human neurons and
astrocytes respond to their chemokine ligands with characteristic
calcium transients.
The presence of chemokine receptors on pyramidal neurons in the
neocortex and hippocampus, areas of HIV/SIV-induced pathology and
clinical impairment (3), is intriguing. Chemokines have
not been considered as a possible neurotoxin, although they are found
in increased amounts within the brains of both patients and macaques
with HIV/SIV encephalitis. The chemokines macrophage inflammatory
protein-1
(MIP-1
),3 MIP-1
, RANTES, and
IFN-inducible protein of 10 kDa (IP-10) have all been found to be
up-regulated in the brains of macaques with SIV encephalitis in vivo
(16). Increased amounts of MIP-1
and MIP-1
mRNAs
have been detected in microglia and astrocytes in brains of patients
with HIV encephalitis by RT-PCR (15), and monocyte
chemoattractant protein-1 (MCP-1), MIP-1
, and RANTES have been
detected within characteristic microglial nodules in postmortem brain
specimens from patients with HIV encephalitis (33).
In addition, stromal-derived factor-1
(SDF-1
) has been shown to induce apoptosis in both NT2 cells and
lymphocytes in vitro (39, 40). Finally, in vitro studies
have demonstrated that HIV and SIV envelope proteins, via binding to
CXCR4 and CCR5, induce signal transduction and chemotaxis in
lymphocytes (41, 42), competitively inhibit chemokine
binding to receptors (43), and induce calcium flux and
apoptosis in neurons (39, 44, 45). The expression of
HIV/SIV coreceptors on neurons suggests a possible mechanism by which
chemokines or HIV/SIV proteins can directly interact with these
nonimmune cells, disrupting their normal function.
We hypothesize that elevated levels of chemokines and/or virus in the
CNS of HIV/SIV-infected subjects could contribute to the pathogenesis
of AIDS dementia through direct interactions with chemokine receptors
expressed on neurons and astrocytes. Here we show that cultured human
and macaque fetal neurons and astrocytes express chemokine receptors
immediately ex vivo and after 2 wk in culture. These receptors are
present in unique distribution patterns on the surfaces of both neurons
and astrocytes, and chemokine ligands produce increases in
intracellular calcium in these cell types, which are neutralized by
mAbs to each receptor. In addition, neuron and astrocyte responses to
chemokines are abolished by pretreatment of cells with pertussis toxin.
We also show that gp120 from SIVmac239 produces similar calcium flux
responses in fetal macaque neurons, which can be blocked by
pretreatment with CCR5 chemokine ligands. These results indicate that
neural chemokine receptors signal through pathways similar to those
within leukocytes and suggest a direct mechanism by which chemokines
and/or viral envelope could contribute to neuronal dysfunction and loss
in the neuropathogenesis of AIDS.
 |
Materials and Methods
|
|---|
Cell cultures
Neuronal cultures.
Fetal brains were obtained from human abortuses between 17 and 20 wk of
gestation from the Brigham and Womens Hospital (Boston, MA) with
approval from the human studies committee (IRB protocol 98-08793) and
from second trimester fetal macaques obtained via caesarian section.
Animals were housed in accordance with standards of the American
Association for Accreditation of Laboratory Animal Care. The
investigators adhered to the "Guide for the Care and Use of
Laboratory Animals" prepared by the Committee on Care and Use of
Laboratory Animals of the Institute of Laboratory Resources, National
Research Council. The human and macaque brains were handled
identically. The meninges were removed, and cortical tissue was
mechanically dissociated using sterile scalpel blades and washed in
sterile PBS. Cells were pelleted by centrifugation at 800 rpm for 10
min, and the pellet was subsequently enzymatically dissociated with
0.25% trypsin in the presence of DNase (50 µg/ml) at 37°C for 30
min. Cells were further mechanically dissociated through a 150-µm
pore size nylon mesh filter and washed again in sterile PBS by
centrifugation at 1800 rpm for 10 min. The collected cell pellet was
mechanically dissociated by trituration and further enzymatically
dissociated with DNase (50 µg/ml) for 10 min. After several further
washes with sterile PBS, cells were seeded onto
poly-D-lysine-coated glass coverslips or T75 flasks at a
density of 1 x 106 cells/ml in DMEM/10%
FCS. 5-Fluoro-2'-deoxyuridine (FDU; 10 µM), a uridine analogue that
is toxic to dividing astrocytes, was added to cultures to inhibit
overproliferation of glial cells on days 5, 8, and 12 in vitro. Cells
were used for single- and double-label immunocytochemical techniques
and calcium flux analyses after
2 wk in culture.
Astrocyte cultures.
Brains were prepared as described above, but seeded instead into T75
flasks at a concentration of 1 x 107
cells/ml. After 1 wk in culture, nonadherent neurons were washed off
with PBS, and adherent cells were treated with 0.25% trypsin for 5 min
at 37°C and reseeded into new T75 flasks at a ratio of 1:2 in
DMEM/10% FCS. After an additional week in culture, cells were again
treated with trypsin and reseeded onto poly-D-lysine-coated
glass coverslips or T75 flasks at a density of 1 x
106 cells/ml. Cells were fed DMEM/10% FCS
biweekly for an additional week and then used for immunocytochemical
and calcium flux analyses. These cultures are
90% pure, as
determined by GFAP immunocytochemical analysis.
Analysis of chemokine receptor expression by flow cytometry and
immunocytochemistry
Brains were prepared as described above and placed in culture in
T75 flasks for 1 day, and then enriched neurons and nonneuronal cells
were obtained via their differential adherence properties. Whereas
nonadherent neurons remained floating in clusters for 1 day, glia,
consisting of enriched (>90%) astrocytes and rare (<10%)
macrophages/microglia, adhered during the first day. The nonadherent
neurons were washed off with PBS, and the adherent cells were lightly
trypsinized to remove them from the flasks. Nonadherent neurons and
adherent glial cells were then analyzed by flow cytometry at
106/ml for chemokine receptor expression.
Briefly, cells were washed twice with PBS and incubated with CXCR4-PE
(clone 12G5; 20 µl/test; PharMingen, San Diego, CA), biotinylated
CCR5 (clone 5C7; 5 µg/ml; LeukoSite, Cambridge, MA) plus streptavidin
670 (2.5 µg/test; Life Technologies, Grand Island, NY), and CCR3
(clone 7B11; 45 µg/ml; LeukoSite, Cambridge, MA) (46)
for 20 min at 4°C. Cells incubated with mAbs to CCR3 were washed with
PBS and incubated in goat anti-mouse PE (20 µl/test; Becton
Dickinson, Franklin Lakes, NJ) for 20 min at 4°C. Cells were then
washed in PBS, fixed in 2% paraformaldehyde overnight, and used for
analysis. Controls consisted of cells incubated with IgG1-FITC and
IgG2a-PE (20 µl/test; Becton Dickinson, Franklin Lakes, NJ), goat
anti-mouse PE alone, streptavidin 670 alone, and omission of
primary Abs. To determine the percentages of neural cell type
populations, aliquots of the same cells were also cytospun onto glass
slides and analyzed via immunocytochemistry for expression of
neuron-specific microtubule-associated protein-2 (MAP-2; 10 µg/ml;
Sigma), the astrocyte marker glial fibrillary acidic protein (GFAP,
510 µg/ml; Dako), and CD11b (10 µg/ml; Immunotech, Westbrook,
ME), which is a monocyte/myeloid Ag found on all brain
macrophages/microglia.
Double-label immunofluorescence and confocal microscopy
In all immunocytochemical experiments, cells were washed twice
with sterile PBS, fixed in 4% paraformaldehyde for 1 h, washed an
additional two times with sterile PBS, and then stored under sterile
PBS until analyzed. Characterization of cell types within our 2- to
3-wk cultures was performed using polyclonal Abs to neuron-specific
enolase (NSE; 1:100; Dako, Carpenteria, CA) and GFAP as above, which
were detected via avidin-biotin-peroxidase complexes (Biogenex, San
Ramon, CA) with diaminobenzadene and Mayers hematoxylin counterstain,
as previously described (26). In all experiments, cells
were treated for 1 h with 10% normal horse serum, 10% normal
goat serum, and 5% human AB serum in sterile PBS to block nonspecific
binding before placement of primary Abs. Cultures were found to contain
7080% neurons and 2025% astrocytes. The remaining cells
(<5%, NSE-, GFAP-) were
morphologically identifiable as macrophages/microglia. Double-label
immunofluorescence was performed using mAbs to chemokine receptors CCR3
(clone 7B11), CCR5 (biotinylated; clone 5C7), and CXCR4 (clone 12G5) at
510 µg/ml and anti-MAP-2 and anti-GFAP as described above,
with or without topro-3 (Molecular Probes, Eugene, OR) staining to
identify cell nuclei. When double immunofluorescence was performed
using chemokine receptor (CCR) and MAP-2 mAbs, cells were treated with
anti-CCR first, and an additional blocking step was performed
before addition of anti-MAP-2. IgG2A isotype controls were used at
a concentration of 10 µg/ml (Dako). Chemokine mAbs and isotype
controls were detected using secondary anti-mouse Abs conjugated
with Texas Red (1/200; Sigma) or streptavidin Texas Red (1/50; Sigma).
MAP-2 and GFAP were detected using FITC-conjugated anti-mouse and
anti-rabbit secondary Abs (1/200; Sigma), respectively. Stained
cells were examined by routine epifluorescence and confocal microscopy.
For epifluorescence, cells were visualized and images captured using a
Vanox S research microscope (Olympus, Lake Success, NY) equipped with
Texas Red and FITC filter sets coupled to an Optronics DEI-750 camera
(Optronics, Goleta, CA). Individual images were then superimposed using
Photoshop (Adobe Systems, Mountain View, CA) to demonstrate the
heterogeneity of chemokine receptor expression in the various cell
types. Confocal microscopy was performed using a Leica TCS SP laser
scanning microscope (Leica, Microsystems, Exton, PA) fitted with a
x100 Leica objective (PL APO, 1.4 NA), and using the Leica image
software. Images were collected at 512 x 512 pixel resolution.
The stained cells were optically sectioned in the z-axis,
and the images in the different channels (photomultiplier tubes) were
collected simultaneously. The step size in the z-axis was
varied from 0.20.5 µm to obtain 3050 slides/imaged field. The
images were transferred to a Macintosh G3 (Apple Computer, Cupertino,
CA) computer and NIH Image v1.61 software was used to render the
images.
Calcium flux analysis
Neural cells were prepared as described above, seeded onto
110-µm-thick coverslips, and cultured as above. Cells were washed
with PBS and loaded with 5 µM fura-2 (Molecular Probes, Eugene, OR)
for 1 h in a dark chamber at 37°C. Cells were then washed with
PBS, and DMEM/1% FCS was added to the cultures. Cells were kept at
37°C until analyzed for calcium flux responses (up to 1 h). For
calcium flux analysis, coverslips were placed into a 37°C warming
chamber and examined under an inverted microscope connected to a
spectrofluorometer. Groups of three to eight neurons or one to three
astrocytes were analyzed for their responses to stimulation with
various chemokines and BSA at a concentration of 100 ng/ml. Additional
experiments were performed after pretreatment of human neuronal and
astrocyte cultures with 200 ng/ml pertussis toxin or 10 µg/ml mouse
mAbs to CCR3 (clone 7B11), CCR5 (clone 2D7), and CXCR4 (clone 12G5).
Fetal macaque neurons were also tested for response to 10 nM
recombinant SIVmac239 gp120 (gift from J. Sodroski, purified as
previously described (47)). This particular envelope
protein is monomeric and thus does not require CD4 to bind CCR5
(47, 48). For experiments with neurons, cells were
predepolarized with 20 mM KCl before exposure to chemokines. Calcium
flux tracings were analyzed for the maximum increase in intracellular
calcium according to the formula [Ca]i =
kd [(R -
Rmin/(Rmax - R)],
assuming a Kd of 224 nM, and
R is the ratio of fluorescence at 340 and 380 nM, as
previously described (49). Rmax
reflects the amount of calcium increase after treatment with the
nonspecific calcium ionophore ionomycin (5 µg/ml), and
Rmin reflects the level of calcium following calcium
chelation with Tris-EDTA. Calcium concentrations are expressed as the
mean ± SE.
 |
Results
|
|---|
Fetal macaque and human brain cells express CCR3, CCR5, and CXCR4
Fetal macaque brain cells were examined immediately ex vivo to
determine the percentage of neuronal and glial cells expressing
chemokine receptors before culture. Populations were separated via
their differential adherence properties, as described in
Materials and Methods, with neurons being nonadherent and
astrocytes and microglia being adherent, and analyzed by flow cytometry
at 106 cells/ml for chemokine receptor
expression. In Fig. 1
A, a
phase-contrast photograph depicts fetal neural cells containing
floating clusters of neurons (arrow) overlying adherent glial cells.
When the nonadherent cells were removed and cultured separately, >95%
of these cells were positive for expression of the neuronal marker
MAP-2 (Fig. 1
B), with contaminating cells positive for the
astrocyte marker GFAP or the microglia marker CD11b (data not shown).
Flow cytometric analysis of nonadherent macaque brain cells
demonstrated that
13% of the neurons stained positive for CCR3,
34% were positive for CCR5, and 28% were positive for CXCR4 (Fig. 1
C). These percentages are consistent with the heterogeneity
in neuronal expression observed in adult macaque brain in vivo
(26). Similar analysis of chemokine receptor expression
was performed on the adherent cell population, which contained >90%
astrocytes and <10% macrophages/microglia. Approximately 90% of
cells stained positive for CCR5, and 86% were positive for CXCR4 (Fig. 1
D). In addition,
14% of these cells demonstrated
expression of CCR3 (Fig. 1
D); however, most of the
CCR3+ cells are likely to be
macrophages/microglia based on immunocytochemical characterization of
cytospun samples (see Materials and Methods; data not
shown). The data suggest that astrocytes express CCR5 and CXCR4.
Isotype-matched control mAbs did not produce staining beyond background
autofluorescence. These experiments, performed on fetal brain cells
immediately ex vivo, suggest that a significant fraction of fetal brain
cells express chemokine receptors in vivo.

View larger version (53K):
[in this window]
[in a new window]
|
FIGURE 1. Chemokine receptors CCR3, CCR5, and CXCR4 are present on fetal macaque
brain cells immediately ex vivo. A, Phase-contrast
photograph of dissociated macaque fetal brain cells after 24 h in
culture. Clusters of floating neurons (arrow) can be seen overlying
adherent glial cells. B, Removal and reculturing of
neuronal clusters from mixed cultures produces >95% pure
MAP-2-positive neurons. Cells were stained with mAb against MAP-2,
which was detected with FITC-conjugated secondary Abs.
C, Flow cytometry of nonadherent neural cells, which
were >95% neurons and expressed CCR3, CCR5, and CXCR4 in the amounts
depicted. D, Flow cytometry of adherent cells after
removal via light trypsinization were a mixture of approximately >90%
GFAP-positive astrocytes and <10% CD11b-positive
macrophages/microglia and expressed CCR5 and CXCR4. Black histograms
depict cellular binding of chemokine receptor mAbs and white histograms
depict similar experiments using isotype-matched control mAbs. Data are
representative of four experiments.
|
|
We next determined whether fetal neural cells would continue to express
chemokine receptors after longer times in culture. Human and macaque
fetal brain cells were treated with FDU to limit astrocyte
proliferation, cultured for 23 wk, and then analyzed by double
immunofluorescence using mAbs to CCR3, CCR5, and CXCR4 and rabbit
polyclonal Ab to GFAP. Immunocytochemical characterization of cultured
macaque neural cells demonstrated that cultures contained 7080%
small, process-bearing cell types positive for NSE (Fig. 2
A), 2025% large cells
positive for GFAP (Fig. 2
B), and <5% small, unstained
cells resembling microglia/macrophages (Fig. 2
A,
arrowheads). Cultured human neural cells contained the same cell types
in similar percentages (data not shown). Immunofluorescence analysis of
chemokine receptor expression in human neurons and astrocytes
demonstrated that subpopulations of neurons and astrocytes express
chemokine receptors in vitro, consistent with our published in vivo
data (26) and the ex vivo data described above. These
cultures contained neurons that stained positively for CCR3 (Fig. 2
C), CCR5 (Fig. 2
D), and CXCR4 (Fig. 2
E) but negatively for GFAP; they appear red. The pattern of
CXCR4 immunostaining appeared more punctate along the neuronal
processes than CCR3 and CCR5 (Fig. 2
, CE). Astrocytes that
did not stain with chemokine receptor mAbs and were positive for GFAP
appear green (Fig. 2
, CE). However, there were a small
percentage of astrocytes that were doubly positive, appearing yellow
(Fig. 2
D). Fig. 2
F demonstrates the expression of
CCR5 in an astrocyte (red staining, left panel); the
cellular identity was verified by the coexpression of GFAP (green
staining, right panel). Isotype-matched mouse mAb controls
did not show staining beyond background autofluorescence. Experiments
using cultured macaque brain cells gave similar results (data not
shown). In general, we observed that the numbers of chemokine
receptor-positive neurons and astrocytes decreased after several weeks
in culture compared with cells tested immediately ex vivo. Thus,
subpopulations of neurons and astrocytes can continue to express
chemokine receptors for at least 23 wk.

View larger version (55K):
[in this window]
[in a new window]
|
FIGURE 2. CCR3, CCR5, and CXCR4 are present on neural cells in culture.
A and B, Replicate 2-wk fetal macaque
neural cultures treated with FDU were characterized using polyclonal
Abs to NSE (A) and GFAP (B), which were
detected via avidin-biotin-peroxidase complexes with diaminobenzadene
(brown) and Mayers hematoxylin counterstain. A, Fetal
macaque neuronal culture demonstrating presence of NSE+
neurons and small NSE- cells (arrowheads), which are
presumed to be microglia. B, Fetal macaque neuronal
culture demonstrating large GFAP+ contaminating astrocytes.
CF, Replicate 2-wk fetal human neural cultures treated
with FDU were double immunofluorescent labeled with mAbs to CCR3
(C), CCR5 (D), CXCR4 (E),
and polyclonal Abs to GFAP. Chemokine primary mAbs were detected using
Texas Red-conjugated secondary Abs and GFAP primary Abs were detected
using FITC-conjugated secondary Abs. Cells were photographed using
Texas Red and FITC filter sets, and then images were superimposed.
C, A group of red CCR3+GFAP-
neurons is seen overlying a green CCR3-GFAP+
astrocyte. D, Red CCR5+GFAP-
neurons are seen among mostly green CCR5-GFAP+
astrocytes. Note the yellow CCR5+GFAP+
astrocyte. E, Red CXCR4+GFAP-
neurons are seen among green CXCR4-GFAP+
astrocytes. F, An example of a double-labeled
CCR5+ (red) and GFAP+ (green) astrocyte viewed
under red (left) and green (right)
filters. Data presented are representative of four separate staining
experiments with both macaque and human fetal neural cultures.
|
|
Chemokine receptors have unique patterns of distribution on
cultured neurons
Given the subtle differences in immunocytochemical staining
patterns of the three chemokine receptors on neurons, we next examined
their expression on neurons and astrocytes via confocal microscopy.
Cells were immunostained as described above and additionally stained
with topro-3 to distinguish the nuclei of cells. The subtle differences
in immunocytochemical staining patterns described above were much more
evident with the increased resolution of confocal microscopy (Fig. 3
). CCR3 (red) density was greatest over
the neuronal cell body (Fig. 3
A), while CCR5 (red) was
evenly distributed over the neuronal cell body and processes (Fig. 3
E). CXCR4 (red), however, was present along the axonal
membrane but was more concentrated in the axon hillock, a cone-shaped
portion of the cell body from which the axon arises, which is known to
be important for summating presynaptic potentials (Fig. 3
F).
All neurons appeared to contain a pool of intracellular receptors
within the cell body, as evident by their presence in all optical
sections through the cell. CCR5 and CXCR4 (both red) were also detected
in GFAP-positive (green) astrocytes, with CCR5 more evenly distributed
over and inside the cell and CXCR4 found predominantly along the edges
of the cell membrane (Fig. 3
, E and F).
Isotype-matched control mAbs revealed that the chemokine receptor
staining was specific (Fig. 3
C). Differential interference
contrast (DIC) images of cells whose staining patterns did not
delineate their entire axonal processes are provided to demonstrate
complete cellular structures (Fig. 3
, B and D).
Similar receptor patterns were observed in human and macaque fetal
neural cultures.

View larger version (31K):
[in this window]
[in a new window]
|
FIGURE 3. Fetal macaque brain cells demonstrate differential distribution of
chemokine receptors CCR3, CCR5, and CXCR4. Replicate 2-wk fetal macaque
neural cultures treated with FDU were double immunolabeled with mAbs to
CCR3, CCR5, and CXCR4 and polyclonal Abs to GFAP. Chemokine primary
mAbs were detected using Texas Red (red)-conjugated secondary Abs, and
GFAP primary Abs were detected using FITC (green)-conjugated secondary
Abs. Nuclei were counterstained with topro-3 (blue). Cells were imaged
using a Leica TCS SP confocal microscope. A, Confocal
imaging of CCR3+GFAP- neuron. Note that most
CCR3 is in the neuronal cell body. B, DIC image of the
same cell as that in A. C, Isotype-matched control
detected using Texas Red (red)-conjugated secondary Abs demonstrates no
red staining of cell body or processes; only nuclei staining with
topro-3 is detected. D, DIC image of same cells as those
in C. E, Confocal imaging of a
CCR5+GFAP- neuron and a
CCR5+GFAP+ astrocyte (inset). Both cells
contain a pool of CCR5 receptor. F, Confocal imaging of
a CXCR4+GFAP- neuron and a
CXCR4+GFAP+ astrocyte (inset).
Note that most receptors are located along the axon in the neuron and
along the edge of the cell membrane in the astrocyte. Data presented
are representative of two separate staining experiments with both
macaque and human (not shown) fetal neural cultures. Bars represent 100
µm.
|
|
To confirm the intracellular chemokine receptor expression pattern,
additional imaging studies were performed on neurons double labeled
with mAbs to chemokine receptors and MAP-2, an intracellular neuronal
marker that is also highly expressed within neuronal cell processes.
CCR3, CCR5, and CXCR4 (all red) and MAP-2 (green) were colocalized
intracellularly (yellow) to varying degrees (Fig. 4
). CCR3 and MAP-2 showed the highest
degree of colocalization (Fig. 4
A), while CCR5 and CXCR4 had
fewer colocalized sites with MAP-2, and multiple surface CXCR4 (red)
receptor sites could be detected along the processes. Isotype-matched
control mAbs detected with Texas Red (red)-conjugated secondary Abs
demonstrated no staining of the cell body or processes and only
intracellular MAP-2 staining (green; Fig. 4
D). The
differences in the distribution patterns of these receptors is likely
to impact their physiological responses to ligand binding and warrants
further study.

View larger version (43K):
[in this window]
[in a new window]
|
FIGURE 4. Fetal human brain cells demonstrate colocalization of chemokine
receptors CCR3, CCR5, and CXCR4 with MAP-2, an intracellular neuronal
cell marker. Replicate 2-wk fetal human neural cultures treated with
FDU were double immunolabeled first with mAbs to CCR3, CCR5, and CXCR4
and then with mAbs to MAP-2. Chemokine primary mAbs were detected using
Texas Red (red)-conjugated secondary Abs, and MAP-2 primary Abs were
detected using FITC (green)-conjugated secondary Abs. Nuclei were
counterstained with topro-3 (blue). Cells were imaged using a Leica TCS
SP confocal microscope. A, Confocal imaging of
CCR3+MAP-2+ neuron. Note that most of the label
for CCR3 is in the neuronal cell body, colocalizing with MAP-2 and
appearing yellow. B, Confocal imaging of a
CCR5+MAP-2+ neuron. There is a small pool of
intracellular CCR5 that colocalized with MAP-2 (yellow).
C, Confocal imaging of a
CXCR4+MAP-2+ neuron. There is less
intracellular CXCR4, with most of the receptors located along the
MAP-2- cell membrane of the axon. D,
Isotype-matched control detected with Texas Red (red)-conjugated
secondary Abs demonstrates no staining; however, MAP-2 staining is
evident throughout cell body and processes (green). Data presented are
representative of two separate staining experiments with both macaque
(not shown) and human fetal neural cultures.
|
|
Chemokines induce calcium flux in cultured fetal neurons and
astrocytes
Although the normal physiological functions of chemokine receptors
in the CNS are unknown, cultured astrocytes, like lymphocytes, have
been shown to respond to SDF-1
and MIP-1
in chemotaxis and
calcium flux assays (38). Thus, we sought to determine
whether activation of neuronal chemokine receptors would produce
increases in intracellular calcium. Using a microscope-based
fluorometer, enriched populations of fura-2-loaded neurons and
astrocytes were analyzed in groups of three to eight neurons or one to
three astrocytes for their relative fluorescence upon treatment with
100 ng/ml of chemokine. Chemokines were chosen for their known
abilities to bind to chemokine receptors CCR3 (eotaxin, RANTES), CCR5
(MIP-1
, RANTES), and CXCR4 (SDF-1
). All these chemokines have
been shown to induce calcium flux in various leukocyte cell types
(25, 49). As shown in Figs. 5
-9, cultured neurons and astrocytes from
both fetal macaque and human brain demonstrated increases in
intracellular calcium concentrations upon treatment with chemokines.
Although the tracings within each panel have been adjusted to the same
scale, the individual tracings were generated using groups of neurons
or astrocytes composed of varying numbers of cells and thus cannot be
quantitatively compared. In neuronal cultures, this response was
significantly enhanced by predepolarization with 20 mM KCl (Fig. 5
).
Fig. 5
A demonstrates this augmentation in the response of
cultured macaque neurons to RANTES, and Fig. 5
B demonstrates
the responses of cultured human neurons to various chemokines after
predepolarization with KCl. BSA, used as a protein control, did not
elicit calcium flux responses (Fig. 5
A), nor did treatment
with the chemokine GRO
, which is a known ligand for chemokine
receptor CXCR2 (Fig. 5
C). Neuronal responses to chemokine
ligands demonstrated homologous, but not heterologous, receptor
desensitization, thus remaining refractory to additional stimulation
with the same chemokine shortly (<50 s) after calcium flux responses
(Fig. 5
C). In cases where one chemokine binds multiple
receptors, such as RANTES (ligand for CCR1, CCR3, and CCR5), additional
calcium responses to chemokine ligands for only one of these receptors
were blocked (Fig. 5
C). In contrast to neurons, cultured
human astrocytes did not require predepolarization with KCl to respond
to chemokines (Fig. 6
). Astrocyte
responses to SDF-1
, RANTES, and MIP-1
were similar to those of
neurons; however, astrocytes did not respond to eotaxin. This was not
surprising given that CCR3 was not detected on this cell type in
appreciable amounts (Fig. 1
D). The addition of mAbs to CCR5
(clone 2D7), CCR3 (clone 7B11), and CXCR4 (clone 12G5) before treatment
with MIP-1
, eotaxin, and SDF-1
, respectively, blocked neuronal
responses to these ligands, but not to ligands that signal through
other, nonneutralized receptors, demonstrating the specificity of these
responses (Fig. 7
). Pretreatment with 200
ng/ml pertussis toxin abolished both neuronal and astrocyte responses
to RANTES, MIP-1
, and SDF-1
(Fig. 8
). In pertussis toxin-treated neurons,
treatment with eotaxin gave inconsistent results, eliciting calcium
flux in approximately half the experiments (data not shown). These
results indicate that CNS chemokine receptor responses are specific and
appear to be coupled to a pertussis toxin-sensitive G protein(s), as
they are on leukocytes.

View larger version (15K):
[in this window]
[in a new window]
|
FIGURE 5. Fetal macaque and human neurons respond to chemokine with increases in
intracellular calcium. Replicate 2-wk fetal macaque and human neural
cultures treated with FDU were loaded with 5 µM fura-2, and groups of
three to eight neurons were visualized and analyzed using a microscope
based single-cell calcium flux apparatus for their responses to 100
ng/ml of chemokine. A, Fetal macaque neurons exposed to
RANTES require predepolarization with 20 mM KCl for maximum response.
BSA (10 nM), used as a control, does not induce a response.
B, Fetal human neurons similarly require
predepolarization with 20 mM KCl to respond to SDF-1 , MIP-1 ,
eotaxin, and RANTES. C, Top and middle
tracings, Fetal human neurons demonstrate homologous, but not
heterologous, receptor desensitization. Note in the middle
tracing that RANTES, which binds both CCR3 and CCR5,
desensitized the eotaxin response. Bottom tracing,
GRO , which binds CXCR2, did not induce calcium flux responses in
chemokine-responsive neurons. Data are presented as the relative ratio
of fluorescence at emission frequency of 510 nm and excitation
frequencies of 340 and 380 nm and are representative of two to five
separate experiments with different neuronal preparations.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
FIGURE 7. Human fetal neurons do not respond to chemokines after pretreatment
with neutralizing chemokine receptor mAbs. Replicate 2-wk fetal human
neural cultures treated with FDU were loaded with 5 µM fura-2, and
groups of three to eight neurons were visualized and analyzed using a
microscope-based, single-cell, calcium flux apparatus for their
response to 100 ng/ml of chemokines after pretreatment with
neutralizing chemokine receptor mAbs. Human fetal neuronal responses to
MIP-1 , eotaxin, and SDF-1 were abolished by pretreatment with
neutralizing mAbs to CCR5 (a; clone 2D7), to CCR3
(b; clone 7B11), and to CXCR4 (c; clone
12G5), respectively. Responses to chemokines that bind nonneutralized
receptors, however, were preserved. Data are presented as the relative
ratio of fluorescence at an emission frequency of 510 nm and excitation
frequencies of 340 and 380 nm and are representative of four separate
experiments per mAb with two different neuronal preparations.
|
|
To test fura-2 loading and to determine maximum intracellular calcium
concentrations, ionomycin, a calcium ionophore, was used to
nonspecifically activate all calcium channels (Fig. 8
B).
Chelation treatment with Tris-EDTA allowed determination of minimum
intracellular calcium concentrations (Fig. 8
B).
Intracellular neuronal calcium concentrations were calculated to range
from 40.5 ± 16.2 nM and increased to 146 ± 51.4 nM
(
4-fold) after predepolarization with KCl. After predepolarization,
the calcium concentrations declined to a new baseline of 83.7 ±
29.6 nM and were increased to 202 ± 95.2 (
5-fold from the
original baseline, but only 2- to 3-fold from the new baseline) after
treatment with chemokines. Astrocyte responses were calculated to be
3-fold from baseline after treatment with chemokines.
SIVmac239 gp120 induces calcium flux in culture fetal macaque
neurons
Fig. 9
depicts representative
tracings of fetal macaque neuronal responses to 10 nM recombinant
monomeric SIVmac239 gp120, a concentration equal to the
Kd for CD4-independent binding of
SIVmac239 gp120 to CCR5 cloned from rhesus macaques (47).
As observed with chemokine treatment, neuronal responses to gp120 were
enhanced by predepolarization with 20 mM KCl, and increases in
intracellular calcium were 2- to 3-fold above the predepolarized
baselines (Fig. 9
a). This response desensitizes MIP-1
signaling, which binds CCR5, and is desensitized by pretreatment with
RANTES, which binds CCR3 and CCR5 (Fig. 9
). These results suggest that
binding of SIVmac239 gp120, which can bind CCR5 in a CD4-independent
manner, produces neuronal calcium flux responses similar to those
observed with chemokine ligands and are likely mediated by
CCR5.

View larger version (24K):
[in this window]
[in a new window]
|
FIGURE 9. Fetal macaque neurons respond to recombinant SIVmac239 gp120 with
increases in intracellular calcium. Replicate 2-wk fetal human neural
cultures treated with FDU were loaded with 5 µM fura-2, and groups of
three to eight neurons were visualized and analyzed using a
microscope-based, single-cell, calcium flux apparatus for response to
10 nM SIVmac239 gp120. a, Fetal macaque neurons exposed
to SIVmac239 gp120 require predepolarization with 20 mM KCl for maximum
response. The gp120-induced response desensitizes a response to 100
ng/ml MIP-1 . b, Response to 10 nM SIVmac239 gp120 is
desensitized by pretreatment with 100 ng/ml RANTES. Data are presented
as the relative ratio of fluorescence at an emission frequency of 510
nm and excitation frequencies of 340 and 380 nm and are representative
of four separate experiments.
|
|
 |
Discussion
|
|---|
We found that the chemokine receptors CCR3, CCR5, and CXCR4 are
present in a subpopulation of macaque and human neurons, and CCR5 and
CXCR4 are present on astrocytes immediately ex vivo and continue to be
expressed on neurons and astrocytes for at least 23 wk in culture.
Thus, chemokine receptor expression is not a cell culture artifact,
providing an in vitro model in which to further examine its role in
neuronal physiology. We also demonstrated that chemokine receptors on
primate neurons respond to their chemokine ligands with transient
increases in intracellular calcium. These data support the in vivo
observations that chemokine receptors are present on subpopulations of
neurons and astrocytes and suggest that these receptors are functional.
The presence of functional chemokine receptors on neurons and
astrocytes provides a mechanism by which viral envelope or the
chemokines known to be produced during CNS HIV/SIV infection could
disrupt normal neurophysiology, contributing to the clinical
manifestations of AIDS dementia complex.
The distribution patterns of chemokine receptors CCR3, CCR5, and CXCR4
on neurons were quite different. CCR3 was most concentrated within the
cell body of neurons, while CCR5 and CXCR4 were found on the axonal
processes and axon hillock regions. Similar differences in the
distribution patterns of these receptors on cultured human neurons have
been reported by others (33). Astrocyte expression of CCR5
and CXCR4 also differed, with a high density of CCR5 found within
intracellular pools and CXCR4 detected along the cell membranes. The
numbers of astrocytes expressing CCR5 and CXCR4 in vitro appeared to
decline after prolonged time in vitro compared with the amount detected
on cells immediately ex vivo, which may explain why these receptors
have not been reported in some other studies (28, 31).
This decline in receptor expression in culture may be due to exposure
to serum factors or loss of neuronal factors in these purified
cultures. Coculturing experiments with neurons and astrocytes may
address these observations.
The differential distribution of CCR3, CCR5, and CXCR4 on fetal macaque
and human neurons may have relevance for synaptic activation and signal
processing. Chemokine receptors concentrated near the neuronal cell
body or axon hillock may regulate amplification of synaptic signals
resulting from activation of other receptor types, such as NMDA or
-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptors,
on distant dendritic sites (50). The requirement of
neuronal predepolarization for chemokine calcium flux responses also
supports a neuromodulatory role. Thus, the presence of chemokines in
the CNS during inflammatory states may lead to alterations in neuronal
and astrocyte signaling that may contribute to an impairment of
neuronal function.
During infection with HIV-1 or SIV, increased levels of MIP-1
,
MIP-1
, and RANTES are detected in the brains of macaques and humans
with AIDS encephalitis (15, 26). In addition, others have
demonstrated the in vivo and in vitro expression of monocyte
chemoattractant protein-1, SDF-1, and IP-10 by activated astrocytes
(20, 21, 34, 51, 52). Thus, there are ample sources of
chemokines during CNS infection with HIV/SIV. Here we examined the
effects of these immunologically active molecules on neurons
themselves. We focused on chemokines whose receptors are both known to
be present on neurons and act as HIV/SIV coreceptors. We show that
treatment of neurons and astrocytes with chemokine ligands for CCR3,
CCR5, and CXCR4 produces a 2- to 3-fold increase in intracellular
calcium. The specificity of these responses was demonstrated in
experiments using neutralizing chemokine receptor mAbs. Although CXCR2
has been detected on neurons in adult brain tissue specimens
(37), our fetal neuronal cultures did not respond to one
of its known ligands, GRO
, which is secreted by spinal cord
astrocytes and acts on oligodendrocytes (53). The
expression of CXCR2 by fetal brain cells has not been investigated.
Responses to RANTES, SDF-1
, and MIP-1
were abolished by
pretreatment of neurons and astrocytes with pertussis toxin,
demonstrating that these receptors are coupled to G proteins in these
cells that are similar to those in leukocytes (Fig. 7
).
Gi1
and Gi2
have been
purified from adult bovine brain (54) and levels of
Gi2
mRNA have been shown to increase
significantly from embryonic day 16 to adulthood in the rat cerebral
cortex (55). In contrast to RANTES, SDF-1
, and
MIP-1
, application of eotaxin yielded inconsistent calcium flux in
the presence of pertussis toxin, suggesting coupling of CCR3 to an
alternative nonpertussis toxin-sensitive G protein in neurons. More
complete comparisons between the signal transduction pathways of
chemokine receptors in neurons and leukocytes will be of interest.
Neuronal responses to both chemokines and gp120 differed from those
observed in astrocyte cultures, in that they were affected by membrane
potential. Predepolarization of neurons with 20 mM KCl was required for
meaningful calcium flux responses to all ligands tested. Other studies
have shown similar requirements for calcium transients induced by gp120
in rat neuronal preparations (44). This finding suggests
neuronal chemokine signaling may be modulated by signals produced by
other membrane activity. Alternatively, the abnormal presence of
chemokines in the brain may alter neuronal responses to more classical
neurotransmitters present. Qiu et al. have recently reported that
chronic IL-6 treatment of developing granule neurons increases the
membrane and current response to NMDA, producing an enhanced calcium
signal to IL-6 and enhanced neurotoxicity in vitro (56).
Although IL-6 is a member of a different receptor family, these results
demonstrate the modulation of a normal neurotransmitter receptor by a
cytokine receptor on neurons. In addition, calcium elevation in
astrocytes has been shown to increase their glutamate release,
producing NMDA receptor activation in hippocampal neurons. Thus, the
responses of both neurons and astrocytes to chemokines may be
responsible for neuronal dysfunction through a variety of
mechanisms.
Gp120 has been known to induce neurotoxicity via mechanisms that affect
both calcium concentrations and NMDA receptor activity
(57). Our finding that gp120 produces increases in
intracellular calcium in neurons that appear to be chemokine receptor
mediated suggests an additional mechanism for neuronal dysfunction
during HIV/SIV CNS infection. Others have shown that HIV/SIV viral
envelope proteins bind to chemokine receptors, produce calcium flux
responses in a variety of nonprimate neuronal cell preparations, and
produce apoptosis in neurons in vitro and in vivo (5, 34, 39, 43, 44). We have also recently found that treatment of our neuronal
preparations with various chemokines produced an increase in the level
of apoptosis (unpublished observation). In addition, quantification of
the neuronal marker N-acetylaspartate using proton magnetic
resonance spectroscopy in brain extracts of control and SIV-infected
macaques demonstrated reduced N-acetylaspartate levels in
the SIV-infected animals compared with controls (58),
suggesting SIV-induced neuronal loss. Interestingly, imaging studies
using proton magnetic resonance spectroscopy also suggest damage to
neurons outside of demyelinated plaques in patients with multiple
sclerosis (59), a disease in which chemokine levels are
also known to be elevated (21). Thus the presence of
chemokines and viral proteins may produce persistent calcium influx
leading to either aberrant neuronal signaling and/or loss through
apoptosis, suggesting mechanisms for both the subtle and lethal effects
of HIV/SIV infection on neurons.
The normal function of chemokine receptors on neurons is unknown.
However, the recent finding that cerebellar development was abnormal in
mice lacking CXCR4 (60) suggests that this receptor is
important for CNS development. Similar developmental abnormalities have
not been seen in mice deficient in CCR5 (61). However,
when CNS chemokine levels are elevated during CNS inflammatory states,
the presence of neural chemokine receptors may have consequences for
local neuronal function and survival and may also allow neurons to
relay information that regulates the global CNS response to
inflammation.
 |
Acknowledgments
|
|---|
We thank LeukoSite (Cambridge, MA) for providing mAbs to CCR3 and
CCR5; Dr. Fred Beber and Ms. Kathleen Sirois from the Department of
Pathology, Brigham and Womens Hospital (Boston, MA) for assistance in
the completion of this study.
 |
Footnotes
|
|---|
1 This work was supported by U.S. Public Health Service Grants AI01519 (to R.S.K), CA69212 and AI40618 (to A.D.L.), RR00168 (to New England Regional Primate Research Center), NS37654 (to K.C.W.), and NS30769 (to A.A.L) and a grant from the Defense Advance Research Planning Agency. A.A.L. is a recipient of an Elizabeth Glazer Scientist Award, and A.D.L. is a Culpepper Scholar in Medicine. 
2 Address correspondence and reprint requests to Dr. Robyn S. Klein, AIDS Research Center, Massachusetts General Hospital, 149 13th Street, Room 5212D, Charlestown, MA 02129. E-mail address: 
3 Abbreviations used in this paper: MIP, macrophage inflammatory protein; IP-10, IFN-inducible protein of 10 kDa; SDF-1
, stromal-derived factor-1
; MAP-2, microtubule-associated protein-2; GFAP, glial fibrillary acidic protein; FDU, 5-fluoro-2'-deoxyuridine; GFAP, glial fibrillary acidic protein; NSE, neuron-specific enolase; DIC, differential interference contrast; NMDA, N-methyl-D-aspartate. 
Received for publication February 12, 1999.
Accepted for publication May 14, 1999.
 |
References
|
|---|
-
Lipton, S. A., H. E. Gendelman. 1995. Seminars in medicine of the Beth Israel Hospital, Boston: dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 333:521.[Free Full Text]
-
Price, R. W.. 1996. Neurological complications of HIV infection. Lancet 348:445.[Medline]
-
Gendelman, H. E., S. A. Lipton, M. Tardieu, M. I. Bukrinsky, L. M. Nottet. 1994. The neuropathogenesis of HIV-1 infection. J. Leukocyte Biol. 56:389.[Abstract]
-
Petito, C. K., B. Roberts. 1995. Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146:1121.[Abstract]
-
Shi, B., U. DeGirolami, S. He, S. Wang, A. Lorenzo, J. Busciglio, D. Gabuzda. 1996. Apoptosis induced by HIV-1 infection of the central nervous system. J. Clin. Invest. 98:1979.[Medline]
-
Lackner, A. A.. 1996. Neuroinvasion and the neuropathogenesis of HIV infection. Brain Pathol. 6:12.
-
Takahasi, K., S. L. Wesselingh, D. E. Griffin, J. E. McArthur, R. T. Johnson, J. D. Glass. 1996. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39:705.[Medline]
-
Toggas, S. M., E. Masliak, E. M. Rockenstein, G. F. Rall, C. R. Abraham, L. Mucke. 1994. Central nervous system damage produced by the expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188.[Medline]
-
Ohagen, A., S. Ghosh, J. He, Y. Chen, G. Shaw, D. Gabuzda. 1999. Apoptosis induced by infection of primary brain cultures with diverse HIV-1 isolates: evidence for a role of the envelope. J. Virol. 73:897.[Abstract/Free Full Text]
-
Sabatier, J. M., E. Vives, K. Mabrouk, A. Benjouad, H. Rochat, A. Duval, B. Hue, E. Bahraou. 1991. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65:961.[Abstract/Free Full Text]
-
Nath, A., K. Psooy, C. Martin, B. Knudsen, D. S. Magnuson, N. Haughey, J. D. Geiger. 1996. Identification of a human immunodeficiency virus type 1 tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70:1475.[Abstract]
-
Dawson, V. L., T. M. Dawson, G. R. Uhl, S. H. Snyder. 1993. HIV-1 protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA 90:3256.[Abstract/Free Full Text]
-
Esser, R., W. Glienke, R. Andreesen, R. E. Unger, M. Kreutz, H. Rubsamen-Waigmann, H. von Briesen. 1998. Individual cell analysis of the cytokine repertoire in human immunodeficiency virus-1-infected monocytes/macrophages by a combination of immunocytochemistry and in situ hybridization. Blood 91:4752.[Abstract/Free Full Text]
-
Persidsky, Y., M. Buttini, J. Limoges, P. Bock, H. E. Gendelman. 1997. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J. Neurovirol. 3:401.[Medline]
-
Schmidtmayerova, H., H. S. L. M. Nottet, G. Nuovo, T. Raabe, C. R. Flanagan, L. Dubrovsky, H. E. Gendelman, A. Cerami, M. Bukrinsky, B. Sherry. 1996. Human immunodeficiency virus type 1 infection alters chemokine
peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 93:700.[Abstract/Free Full Text]
-
Sasseville, V. G., M. M. Smith, C. R. Mackay, D. R. Pauley, K. G. Mansfield, D. J. Ringler, A. A. Lackner. 1996. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am. J. Pathol. 149:1459.[Abstract]
-
Weiss, L., A. Si-Mohamed, P. Giral, P. Castiel, A. Ledur, C. Blondin, M. D. Kazatchkine, N. Haeffner-Cavaillon. 1997. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1
and RANTES correlate with virus load in human immunodeficiency virus infection. J. Infect. Dis. 176:1621.[Medline]
-
Benveniste, E. N., J. Kwon, W. J. Chung, J. Sampson, K. Pandya, L. P. Tang. 1994. Differential modulation of astrocyte cytokine gene expression by TGF-
. J. Immunol. 153:5210.[Abstract]
-
McManus, C. M., C. F. Brosnan, J. W. Berman. 1998. Cytokine induction of MIP-1
and MIP-1
in human fetal microglia. J. Immunol. 160:1449.[Abstract/Free Full Text]
-
Ransohoff, R. M., T. A. Hamilton, M. Tani, M. H. Stoler, H. E. Shick, J. A. Major, M. L. Estes, D. M. Thomas, V. K. Tuohy. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:592.[Abstract]
-
Simpson, J. E., J. Newcombe, M. L. Cuzner, M. N. Woodroofe. 1998. Expression of monocyte chemoattractant protein-1 and other
-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 84:238.[Medline]
-
Dragic, T., A. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, et al 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667.[Medline]
-
Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Pelper, M. Parmentier, R. G. Collman, R. W. Doms. 1996. Dual-tropic primary HIV-1 isolate that uses fusin and the
-chemokine receptors CKR-5, CKR-3, CKR-2b as fusion cofactors. Cell 85:1149.[Medline]
-
Feng, Y., C. C. Broder, P. E. Kennedy, E. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872.[Abstract]
-
Luster, A.. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.[Free Full Text]
-
Westmoreland, S. V., J. B. Rottman, K. C. Williams, A. A. Lackner, V. G. Sasseville. 1998. Chemokine receptor expression on resident and inflammatory cells in the brains of macaques with simian immunodeficiency virus encephalitis. Am. J. Pathol. 152:659.[Abstract]
-
Rottman, J. B., K. P. Ganley, K. Williams, L. Wu, C. Mackay, D. J. Ringler. 1997. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151:1341.[Abstract]
-
Lavi, E., J. M. Strizki, A. M. Ulrich, W. Zhang, L. Fu, Q. Wang, M. OConnor, J. A. Hoxie, F. Gonzalez-Scarano. 1997. CXCR-4 (fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am. J. Pathol. 151:1035.[Abstract]
-
Zhang, L., T. He, A. Talal, G. Wang, S. S. Frankel, D. D. Ho. 1998. In vivo distribution of human immunodeficiency virus/simian immunodeficiency virus coreceptors CXCR4, CCR3 and CCR5. J. Virol. 72:5035.[Abstract/Free Full Text]
-
Xia, M. Q., S. X. Qin, L. J. Wu, C. R. Mackay, B. T. Hyman. 1998. Immunohistochemical study of the
-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimers disease brains. Am. J. Pathol. 153:31.[Abstract/Free Full Text]
-
Vallat, A. V., U. De Girolam, J. He, A. Mhashilkar, W. Marasco, B. Shi, F. Gray, J. Bell, C. Keohane, T. W. Smith, et al 1998. Localization of HIV-1 coreceptors CCR5 and CXCR4 in the brain of children with AIDS. Am. J. Pathol. 152:167.[Abstract]
-
He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, et al 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645.[Medline]
-
Sanders, V. J., C. A. Pittman, G. W. White, C. A. Wiley, C. L. Achim. 1998. Chemokines and receptors in HIV encephalitis. AIDS 12:1021.[Medline]
-
Ohtani, Y., M. Minami, N. Kawaguchi, A. Nishiyori, J. Yamamoto, S. Takami, M. Satoh. 1998. Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells. Neurosci. Lett. 249:163.[Medline]
-
Meucci, O., A. Fatatis, A. A. Simen, T. J. Bushell, P. W. Gray, R. J. Miller. 1998. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95:14500.[Abstract/Free Full Text]
-
Hesselgesser, J., M. Halks-Miller, V. DelVecchio, S. C. Peiper, J. Hoxie, D. L. Kolson, D. Taub, R. Horuk. 1997. CD4-independent associate between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr. Biol. 7:112.[Medline]
-
Horuk, R., A. W. Martin, Z. Wang, L. Schwietzer, A. Gerassimides, H. Guo, Z. Lu, J. Hesselgesser, H. D. Perez, J. Kim, et al 1997. Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 158:2882.[Abstract]
-
Tanabe, S., M. Heesen, I. Yoshizawa, M. A. Berman, Y. Luo, C. C. Bleul, T. A. Springer, K. Okuda, N. Gerard, M. E. Dorf. 1997. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J. Immunol. 159:905.[Abstract]
-
Hesselgesser, J., D. Taub, P. Baskar, M. Greenberg, J. Hoxie, D. L. Kolson, R. Horuk. 1998. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1
is mediated by the chemokine receptor CXCR4. Curr. Biol. 8:595.[Medline]
-
Herbein, G., U. Mahlknecht, F. Batliwalla, P. Gregersen, T. Pappas, J. Butler, W. A. OBrien, E. Verdin. 1998. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395:189.[Medline]
-
Weissman, D., R. L. Rabin, J. Arthos, A. Rubbert, M. Dybul, R. Swofford, S. Venkatesan, J. M. Farber, A. S. Fauci. 1997. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389:981.[Medline]
-
Davis, C. B., I. Dikic, D. Unutmaz,
C. M. Hill, J. Arthos, M. A.
Siani, D. A. Thompson, J. Schlessinger,
and D. R. Littman. Signal transduction due to HIV-1
envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med.186:1793.
-
Madani, N., S. L. Kozak, M. P. Kavanaugh, D. Kabat. 1998. Gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5. Proc. Natl. Acad. Sci. USA 95:8005.[Abstract/Free Full Text]
-
Lo, T. K., C. J. Fallert, T. M. Piser, S. A. Thayer. 1992. HIV-1 envelope protein evokes intracellular calcium oscillation in rate hippocampal neurons. Brain Res. 594:189.[Medline]
-
Nath, A., R. A. Padua, J. D. Geiger. 1995. HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium. Brain Res. 678:200.[Medline]
-
Heath, H., S. Quin, P. Rao, G. LaRosa, N. Kassam, P. D. Ponath, C. R. Mackay. 1997. Chemokine receptor usage by human eosinophils: the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178.[Medline]
-
Martin, K. A., R. Wyatt, M. Farzan, H. Choe, L. Marcon, E. Desjardins, J. Robinson, J. Sodroski, C. Gerard, N. P. Gerard. 1997. CD4-independent binding of SIV gp120 to rhesus CCR5. Science 278:1470.[Abstract/Free Full Text]
-
Edinger, A. L., J. L. Mankowski, B. J. Doranz, B. J. Margulies, B. Lee, J. Rucker, M. Sharron, T. L. Hoffman, J. F. Berson, M. C. Zink, et al 1997. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc. Natl. Acad. Sci. USA 94:14742.[Abstract/Free Full Text]
-
Rothenberg, M. E., R. Ownbey, P. D. Mehlhop, P. M. Loiselle, M. van de Rijn, J. V. Bonventre, H. C. Oettgen, P. Leder, A. D. Luster. 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol. Med. 2:334.[Medline]
-
Dodt, H. U., A. Frick, K. Kampe, W. Zieglgansberger. 1998. NMDA and AMPA receptors on neurocortical neurons are differentially distributed. Eur. J. Neurosci. 10:3351.[Medline]
-
McManus, C., J. W. Berman, F. M. Brett, H. Staunton, M. Farrell, C. F. Brosnan. 1998. MCP-1, MCP-2, and MCP-3 expression in multiple sclerosis lesions: and immunohistochemical and in situ hybridization study. J. Neuroimmunol. 86:20.[Medline]
-
Hayashi, M., Y. Luo, J. Laning, R. M. Strieter, M. E. Dorf. 1995. Production and function of monocyte chemoattractant protein-1 and other
-chemokines in murine glial cells. J. Neuroimmunol. 60:143.[Medline]
-
Robinson, S., M. Tani, R. M. Strieter, R. M. Ransohoff, R. H. Miller. 1998. The chemokine growth-regulated oncogene-
promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci. 18:10457.[Abstract/Free Full Text]
-
Lang, J.. 1989. Purification and characterization of subforms of the guanine-nucleotide-binding proteins G
I and G
o. Eur. J. Biochem. 183:687.[Medline]
-
Eriksson, P. S., M. Nilsson, G. L. Matejka. 1995. Distribution and development of G
i2 mRNA in the rat cerebral cortex investigated with in situ hybridization and RNase protection assay. Brain Res. Dev. 84:208.[Medline]
-
Qiu, Z., D. D. Sweeney, J. G. Netzeband, D. L. Gruol. 1998. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J. Neurosci. 18:10445.[Abstract/Free Full Text]
-
Lipton, S. A.. 1994. AIDS-related dementia and calcium homeostasis. Ann. NY Acad. Sci. 747:205.[Abstract]
-
Tracey, I., J. Lane, I. Chang, B. Navia, A. Lackner, R. G. Gonzalez. 1997. 1H magnetic resonance spectroscopy reveals neuronal injury in a simian immunodeficiency virus macaque model. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:21.[Medline]
-
Husted, C. A., D. S. Goodin, J. W. Hugg, A. A. Maudsley, J. S. Tsurada, S. H. de Bic, G. Fein, G. B. Matson, M. W. Weine